Synergy of Small Molecular Inhibitors of Hepatitis C Virus Replication Directed at Multiple Viral Targets
- 15 March 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (6) , 3005-3008
- https://doi.org/10.1128/jvi.02083-06
Abstract
Chronic hepatitis C virus (HCV) infection is a significant worldwide health problem with limited therapeutic options. A number of novel, small molecular inhibitors of HCV replication are now entering early clinical trials in humans. Resistance to small molecular inhibitors is likely to be a significant hurdle to their use in patients. A systematic assessment of combinations of interferon and/or novel anti-hepatitis C virus agents from several different mechanistic classes was performed in vitro. Combinations of inhibitors with different mechanisms of action consistently demonstrated more synergy than did compounds with similar mechanisms of action. These results suggest that combinations of inhibitors with different mechanisms of action should be prioritized for assessment in clinical trials for chronic hepatitis C virus infection.Keywords
This publication has 34 references indexed in Scilit:
- Late breaking abstractsHepatology, 2006
- VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon CellsAntimicrobial Agents and Chemotherapy, 2006
- 731 Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting hcv polymerase in chronic HCV patientsJournal of Hepatology, 2006
- Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymeraseBioorganic & Medicinal Chemistry Letters, 2006
- Effect of Interaction between Hepatitis C Virus NS5A and NS5B on Hepatitis C Virus RNA Replication with the Hepatitis C Virus RepliconJournal of Virology, 2004
- Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine InhibitorAntimicrobial Agents and Chemotherapy, 2003
- Projecting future complications of chronic hepatitis C in the United StatesLiver Transplantation, 2003
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United StatesHepatology, 2000
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996